Cortexyme to host symposium at aaic 2021

South san francisco, calif.--(business wire)---- $crtx--cortexyme, inc. (nasdaq: crtx), a company advancing a pivotal trial in alzheimer's disease with top-line data expected in the fourth quarter of 2021 and a growing pipeline of therapeutics for degenerative diseases, announced that it will host a corporate sponsored symposium and dinner held in conjunction with the alzheimer's association international conference® 2021 (aaic®) taking place july 26-30, 2021, in denver, colorado, as well as virtually. t
QNCX Ratings Summary
QNCX Quant Ranking